@article {2690,
	title = {Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.},
	journal = {Journal of addiction medicine},
	volume = {6},
	year = {2012},
	month = {2012 Jun},
	pages = {159-65},
	abstract = {Despite the Centers for Disease Control and Prevention recommendations for annual HIV testing of at-risk populations, including those with substance use disorders, there are no data on the human immunodeficiency virus (HIV) testing practices of buprenorphine-prescribing physicians.},
	keywords = {Adolescent, Adult, AIDS Serodiagnosis, Buprenorphine, Comorbidity, Cross-Sectional Studies, Female, HIV Infections, Humans, Male, Mass Screening, Middle Aged, Narcotics, Opiate Substitution Treatment, Opioid-Related Disorders, Physician{\textquoteright}s Practice Patterns, Questionnaires, Risk-Taking, United States, Utilization Review, Young Adult},
	issn = {1932-0620},
	doi = {10.1521/aeap.2013.25.1.14},
	author = {Edelman, E Jennifer and Dinh, An T and Moore, Brent A and Schottenfeld, Richard S and Fiellin, David A and Sullivan, Lynn E}
}
